Ten‐year follow‐up outcomes of a single intravenous infusion of autologous cord blood mononuclear cells in preterm neonates-Reference-Cited by-同舟云学术

Ten‐year follow‐up outcomes of a single intravenous infusion of autologous cord blood mononuclear cells in preterm neonates

Published:2020-07 Issue:3 Volume:10 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Zhuxiao Ren¹,Fang Xu¹,Chunyi Zhang¹,Jianlan Wang¹,Qi Zhang²,Wenji Zhou¹,Wei Wei³,Qi Wang¹³,Jie Yang¹^ORCID

Affiliation:

1. Department of NeonatologyGuangdong Women and Children HospitalGuangzhou Medical University Guangzhou P. R. China

2. Department of Clinical Genetic CenterGuangdong Women and Children HospitalGuangzhou Medical University Guangzhou P. R. China

3. Guang Dong Cord Blood and Stem Cell Bank Guangzhou P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.144

Reference10 articles.

1. Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies

2. Safety of Autologous Cord Blood Cells for Preterms: A Descriptive Study

3. Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia

4. Feasibility of Autologous Cord Blood Cells for Infants with Hypoxic-Ischemic Encephalopathy

5. Clinical evaluation of the safety and feasibility of whole autologous cord blood transplant as a source of stem and progenitor cells for extremely premature neonates: preliminary report;Rudnicki J;Exp Clin Transplant,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes;eClinicalMedicine;2023-03

2. Autologous cord blood mononuclear cell infusion for the prevention of bronchopulmonary dysplasia in very preterm monozygotic twins: A study protocol for a randomized, placebo-controlled, double-blinded multicenter trial;Frontiers in Pediatrics;2022-12-09

3. Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy;Stem Cells International;2022-05-11